Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.3 [1.12-1.52],0.000811613018168584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CFD,Complement factor D,Inverse variance weighted,11,1.25 [1.09-1.44],0.00192905151592421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.9 [1.24-2.9],0.00293227205001308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NRP1,Neuropilin-1,Inverse variance weighted,12,0.82 [0.71-0.94],0.00412348880217061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.08 [1.02-1.13],0.00560112786218045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.07 [1.02-1.12],0.00594951778779364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.15 [1.04-1.27],0.00626993737954364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.17 [1.04-1.31],0.00676974514619666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.47 [1.11-1.95],0.007142823550265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.9 [0.83-0.97],0.00800456069249159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.87 [0.79-0.97],0.0102308970039158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.18 [1.04-1.34],0.011084777229287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.73 [0.58-0.93],0.011666762655083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,8,1.26 [1.05-1.51],0.0117090864917669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.78 [0.64-0.95],0.0132014424581462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.63 [0.43-0.91],0.0151917176703883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SDC1,Syndecan-1,Inverse variance weighted,2,1.49 [1.08-2.05],0.0154101402339263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP3,Stromelysin-1,Inverse variance weighted,34,0.89 [0.81-0.98],0.0154279175679944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.07 [1.01-1.13],0.0170745660377522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,0.91 [0.84-0.99],0.0203945909096443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSC2,Desmocollin-2,Inverse variance weighted,9,0.83 [0.71-0.97],0.0225489117044315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.25 [1.03-1.52],0.0250241202207634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LMNB2,Lamin-B2,Wald ratio,1,3.48 [1.16-10.44],0.0260227666135971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.31 [1.03-1.67],0.0261150270414576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.18 [1.02-1.36],0.0269268953180264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.48 [0.25-0.92],0.027808457682207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.31 [1.03-1.67],0.0307817245639649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OCLN,Occludin,Inverse variance weighted,2,1.45 [1.03-2.04],0.0317431111013465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.06 [1-1.12],0.0334207429507604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.75 [0.58-0.98],0.0360200340451822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.17 [1.01-1.35],0.0393014467500135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,F3,Tissue factor,Inverse variance weighted,11,1.19 [1.01-1.4],0.0418872144536655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.29 [1.01-1.65],0.0423855072567834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.26 [1.01-1.58],0.0439870652176269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.89 [0.79-1],0.0451652252789062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.28 [0.08-0.98],0.0461724597151786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FBLN2,Fibulin-2,Inverse variance weighted,11,0.89 [0.8-1],0.0468918038764038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.87 [0.75-1],0.0503478644198807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.08 [1-1.16],0.0505414584651593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.14 [1-1.3],0.0525694245474021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AREG,Amphiregulin,Inverse variance weighted,3,0.75 [0.56-1],0.0526173521594073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.13 [1-1.28],0.0527018661418371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.09 [0.99-1.19],0.0656778973974363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.14 [0.99-1.31],0.0661241127033147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.59 [0.97-2.6],0.0661734715878298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.44 [0.97-2.15],0.0687481120362247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.82 [0.66-1.02],0.069173737112062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.9 [0.8-1.01],0.0695620187199224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.94 [0.88-1.01],0.0707895273138174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,1.11 [0.99-1.25],0.0723838063594639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,6,1.09 [0.99-1.2],0.0730389233832005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.87 [0.75-1.01],0.0747925479842543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.19 [0.98-1.44],0.075892903486444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.08 [0.99-1.18],0.0765863477993337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.88 [0.76-1.01],0.0775237880839898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.48 [0.95-2.31],0.0794577897316263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.91 [0.82-1.01],0.083039364407172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.39 [0.96-2.01],0.0830413496113451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.79 [0.61-1.03],0.0871412907592429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.82 [0.66-1.03],0.0885406292824489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.94 [0.87-1.01],0.0889528686181585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.83 [0.67-1.03],0.0889889374006886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.06 [0.99-1.12],0.0909477125034622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.95 [0.89-1.01],0.0950321259334762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.68 [0.44-1.07],0.0967278525594121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH1,Protocadherin-1,Wald ratio,1,0.64 [0.37-1.1],0.104521683972686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,UMOD,Uromodulin,Inverse variance weighted,29,1.05 [0.99-1.13],0.105961117875252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.74 [0.89-3.4],0.106631704691522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.08 [0.98-1.2],0.109835332656733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.72 [0.47-1.08],0.110509622966282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.95 [0.89-1.01],0.112184899820061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.25 [0.95-1.65],0.114765518927889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.17 [0.96-1.42],0.119070922226599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,2.26 [0.81-6.33],0.12120428646563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG2,Secretogranin-2,Wald ratio,1,0.47 [0.19-1.22],0.121415652136506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.74 [0.5-1.09],0.123717037204343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.56 [0.27-1.17],0.124070231016817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPPC,C-type natriuretic peptide,Wald ratio,1,0.44 [0.15-1.27],0.129440805283053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.11 [0.97-1.28],0.130073585847503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.16 [0.96-1.42],0.130661341463702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.86 [0.71-1.05],0.131706440395524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.23 [0.94-1.61],0.133170196021021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.82 [0.62-1.07],0.135555100951231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,11,1.16 [0.95-1.42],0.137561678544843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.15 [0.96-1.37],0.141288807411968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.04 [0.99-1.11],0.143886463847185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.17 [0.95-1.46],0.144858885214288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.13 [0.96-1.33],0.145266581022871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.21 [0.93-1.58],0.14820311698269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.95 [0.89-1.02],0.150073970935868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD70,CD70 antigen,Inverse variance weighted,28,0.95 [0.88-1.02],0.150929309168526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.95 [0.89-1.02],0.155504299286549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.47 [0.86-2.51],0.155817923198825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.96 [0.91-1.02],0.157500128078519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK14,Kallikrein-14,Inverse variance weighted,15,1.12 [0.96-1.3],0.157879657279074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.19 [0.93-1.51],0.159547769076868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON1,Spondin-1,Inverse variance weighted,21,0.91 [0.8-1.04],0.162141914005414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.24 [0.92-1.67],0.16223220834295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.88 [0.74-1.05],0.164064342575455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.26 [0.91-1.76],0.165998263286116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.06 [0.98-1.14],0.1692904753673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.9 [0.78-1.05],0.16955541023644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,0.91 [0.79-1.04],0.171320895294187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.32 [0.89-1.96],0.172668711736851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.91 [0.8-1.04],0.174891949428663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.93 [0.84-1.03],0.179233827043159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,28,1.06 [0.97-1.16],0.180742559104646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.06 [0.97-1.15],0.181840635812026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.08 [0.96-1.21],0.183099487722195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.11 [0.95-1.28],0.1838850621501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.55 [0.23-1.33],0.183893622196843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.71 [0.43-1.18],0.184431989671284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.9 [0.77-1.05],0.185374444708368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.9 [0.76-1.06],0.188851616261687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.1 [0.95-1.26],0.190925649056592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.25 [0.9-1.73],0.192272814388899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.24 [0.89-1.73],0.194068256815731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.89 [0.74-1.06],0.196471391456313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD27,CD27 antigen,Inverse variance weighted,9,1.09 [0.96-1.24],0.197015497823795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.96 [0.9-1.02],0.197708366132719,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.19 [0.91-1.54],0.199284127928525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.95 [0.89-1.03],0.202959988300378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.74 [0.46-1.18],0.203030426688468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.68 [0.37-1.24],0.203211056997662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NFASC,Neurofascin,Inverse variance weighted,15,0.93 [0.83-1.04],0.204834606297166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.5 [0.17-1.46],0.206355239137924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.96 [0.89-1.03],0.209205728837106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.95 [0.86-1.03],0.215504626832046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.24 [0.88-1.74],0.216280781957478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD83,CD83 antigen,Inverse variance weighted,5,1.15 [0.92-1.44],0.217211518405034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1.07 [0.96-1.2],0.217314989040933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.91 [0.68-5.33],0.218189396282064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EDN1,Endothelin-1,Inverse variance weighted,3,1.22 [0.89-1.68],0.223536115352394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.07 [0.96-1.18],0.223891740642199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.52 [0.77-3],0.224401383698205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.75 [0.48-1.19],0.225123037949496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NEO1,Neogenin,Wald ratio,1,1.43 [0.8-2.57],0.226672888425513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.82 [0.6-1.13],0.226738858647452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,17,1.06 [0.96-1.17],0.231218357837332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.16 [0.91-1.47],0.233635827104802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.91 [0.77-1.07],0.234650410412001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,0.96 [0.89-1.03],0.235380194816504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.9 [0.76-1.07],0.238687074364892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.79 [0.53-1.17],0.239788988572467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,3,0.84 [0.62-1.13],0.240627565912944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS27,Serine protease 27,Inverse variance weighted,5,0.9 [0.74-1.08],0.24194523895964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,2,0.51 [0.16-1.59],0.244696531806998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.03 [0.98-1.08],0.259126380815658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.8 [0.54-1.19],0.268890552282974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.86 [0.66-1.12],0.269799201567949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.11 [0.92-1.33],0.270130473377443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD48,CD48 antigen,Inverse variance weighted,18,0.96 [0.89-1.03],0.270446021704337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.84 [0.61-1.15],0.270591163349285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.86 [0.66-1.13],0.2733324564822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,1.05 [0.96-1.15],0.274698230861906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.95 [0.86-1.05],0.275520194893711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,1.1 [0.93-1.29],0.278716061238248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.89-1.03],0.279013750203025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.77 [0.47-1.24],0.279454635153759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD302,CD302 antigen,Inverse variance weighted,9,0.92 [0.79-1.07],0.28416042841187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.1 [0.92-1.31],0.286575029373699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,2.01 [0.55-7.31],0.290425231281896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.22 [0.84-1.78],0.290569626486804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.03 [0.98-1.08],0.291439648099079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.94 [0.82-1.06],0.297042888068399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.07 [0.94-1.23],0.297262293042697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VWC2,Brorin,Inverse variance weighted,22,1.06 [0.95-1.18],0.300365915855674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MUC13,Mucin-13,Inverse variance weighted,9,0.9 [0.74-1.1],0.301947120859583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.45 [0.72-2.91],0.301951053993094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,7,0.87 [0.68-1.13],0.302057539592891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.94 [0.84-1.06],0.302517094895472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS1,Galectin-1,Inverse variance weighted,6,0.93 [0.82-1.07],0.303932254362777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.93 [0.82-1.06],0.304776179984177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DRAXIN,Draxin,Inverse variance weighted,13,0.95 [0.86-1.05],0.30481095957303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG2,Desmoglein-2,Inverse variance weighted,11,1.08 [0.93-1.25],0.305091489253332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.96 [0.88-1.04],0.306565599729986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.05 [0.95-1.16],0.307249789283381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK10,Kallikrein-10,Inverse variance weighted,15,0.93 [0.81-1.07],0.309491052387308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN4,Nectin-4,Inverse variance weighted,7,1.08 [0.93-1.26],0.309663752820219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST6,Cystatin-M,Inverse variance weighted,2,0.87 [0.68-1.13],0.309978561329696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.93 [0.8-1.07],0.310503922537291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSB,Cathepsin B,Inverse variance weighted,26,1.05 [0.96-1.14],0.311346749717683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.14 [0.89-1.45],0.312132802793757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.95 [0.87-1.05],0.315448372942582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH17,Cadherin-17,Inverse variance weighted,14,0.93 [0.8-1.08],0.319335906707836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.68 [0.32-1.45],0.32073987879036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.04 [0.97-1.11],0.321563201273803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.95 [0.87-1.05],0.323459959521773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.06 [0.95-1.18],0.323972826696211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.82 [0.55-1.22],0.324960299111936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.05 [0.95-1.17],0.327551182030109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.05 [0.95-1.17],0.330279467249098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAYN,Layilin,Inverse variance weighted,20,0.94 [0.83-1.07],0.341789891269144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.12 [0.88-1.43],0.342111392425902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PENK,Proenkephalin-A,Inverse variance weighted,19,1.06 [0.94-1.2],0.342640244441203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.93 [0.8-1.08],0.344925255545695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,9,1.08 [0.92-1.25],0.349285667208309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.05 [0.95-1.15],0.349991724965148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,3,1.11 [0.89-1.39],0.350872620810535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.12 [0.88-1.41],0.35124042809016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.89 [0.7-1.14],0.351953890163702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI3,Elafin,Inverse variance weighted,10,1.06 [0.93-1.21],0.362434019333576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,26,0.95 [0.86-1.06],0.368715800241502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALB1,Calbindin,Inverse variance weighted,2,0.79 [0.48-1.31],0.369220929568596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.95 [0.84-1.07],0.372034801252696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.06 [0.94-1.19],0.37293460351205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,XCL1,Lymphotactin,Inverse variance weighted,31,0.97 [0.91-1.04],0.378297422532366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.96 [0.87-1.05],0.378606383150754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.89 [0.67-1.16],0.378753142590729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.09 [0.9-1.32],0.379710435402827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,6,0.9 [0.72-1.14],0.381690375391515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.36 [0.68-2.71],0.382118321652606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.82 [0.52-1.29],0.386760411897509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.13 [0.86-1.47],0.388493666571049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,0.93 [0.8-1.09],0.394915062247532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,5,1.08 [0.9-1.3],0.421359452518584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.95 [0.83-1.08],0.424895116904253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.95 [0.83-1.08],0.431169802438051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA2,Apolipoprotein A-II,Wald ratio,1,0.77 [0.39-1.5],0.437981177392386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.07 [0.9-1.26],0.444893020902518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.11 [0.85-1.43],0.448155651036123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.92 [0.73-1.15],0.448635074502394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.95 [0.84-1.08],0.455468137715966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.02 [0.96-1.08],0.457444220728614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.07 [0.9-1.28],0.459593227920394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.95 [0.83-1.09],0.461000103527498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST3,Cystatin-C,Inverse variance weighted,10,0.95 [0.83-1.09],0.461396089839874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM,Paralemmin-1,Inverse variance weighted,6,0.92 [0.74-1.15],0.464748475716493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.88 [0.64-1.23],0.465506805896566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.04 [0.94-1.15],0.471512095831602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.05 [0.92-1.19],0.471875125303991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.05 [0.92-1.2],0.473063093165654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.06 [0.9-1.26],0.473150791167625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PKD1,Polycystin-1,Inverse variance weighted,12,1.06 [0.91-1.23],0.474445981817086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.32 [0.62-2.8],0.474886627251652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGB,Secretogranin-1,Inverse variance weighted,27,1.03 [0.95-1.11],0.476172968885687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.93 [0.76-1.13],0.479420107001794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS8,Prostasin,Inverse variance weighted,5,1.16 [0.76-1.78],0.483726309380345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.04 [0.93-1.17],0.484185887474389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.19 [0.73-1.96],0.485271429851811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.07 [0.88-1.3],0.486510383401676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.07 [0.88-1.31],0.48791956692066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP6,Gastrotropin,Wald ratio,1,0.89 [0.64-1.24],0.488855110279971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.86 [0.57-1.31],0.488950211083167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.5 [0.47-4.8],0.490907192132441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.04 [0.93-1.15],0.493245575402578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.05 [0.91-1.22],0.49844802088568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCA,Calcitonin,Inverse variance weighted,5,1.13 [0.8-1.59],0.499140855799585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.04 [0.92-1.18],0.502957675220406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.89 [0.64-1.25],0.508143679907817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.97 [0.89-1.06],0.508475438811516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP7,Matrilysin,Inverse variance weighted,13,0.96 [0.85-1.08],0.509287582990951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.97 [0.89-1.06],0.51128136573284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.97 [0.87-1.07],0.512802527793982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.97 [0.88-1.07],0.513700422417776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [0.95-1.12],0.518549673796893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPT,Dermatopontin,Inverse variance weighted,21,1.04 [0.93-1.17],0.521224232354851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.89 [0.64-1.26],0.521860680867396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.09 [0.84-1.41],0.523750920025046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.96 [0.85-1.09],0.527914495010946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RBP2,Retinol-binding protein 2,Wald ratio,1,0.79 [0.38-1.64],0.530211064411831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.7 [0.23-2.15],0.532978425748779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.28 [0.58-2.83],0.53461394035428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.88-1.07],0.543793092078043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.98 [0.93-1.04],0.54700202175182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,2,0.91 [0.66-1.24],0.548220445908517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.89 [0.59-1.32],0.55203287627057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.11 [0.78-1.59],0.5535356138002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.06 [0.88-1.28],0.556588019936197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.98 [0.92-1.04],0.560549261514937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EGFLAM,Pikachurin,Inverse variance weighted,19,0.98 [0.91-1.05],0.5622177773841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.7 [0.2-2.41],0.56699608921178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.9 [0.62-1.3],0.56799161432445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,4,1.13 [0.75-1.7],0.56903322472223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.84-1.1],0.570721086917767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH6,Cadherin-6,Inverse variance weighted,29,0.98 [0.91-1.05],0.584592983282829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.93-1.14],0.587740932026243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.04 [0.9-1.2],0.589501615817088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.02 [0.94-1.11],0.591263716104988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL16,Pro-interleukin-16,Inverse variance weighted,16,0.97 [0.87-1.08],0.592346027837748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.24 [0.56-2.76],0.597623014465295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLC,Galectin-10,Wald ratio,1,1.15 [0.68-1.94],0.597845042640509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.05 [0.87-1.26],0.598481574661515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,3,1.17 [0.64-2.12],0.608232439174277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.97 [0.87-1.09],0.612002041172008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRP,Agouti-related protein,Inverse variance weighted,3,0.89 [0.56-1.4],0.615174687444299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MDK,Midkine,Inverse variance weighted,4,1.09 [0.78-1.51],0.616121599446448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.19 [0.59-2.4],0.619128453852523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BSG,Basigin,Wald ratio,1,1.08 [0.79-1.49],0.62098885424665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,0.98 [0.88-1.08],0.62419981380634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.07 [0.82-1.4],0.624526477373383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG3,Desmoglein-3,Inverse variance weighted,7,0.96 [0.82-1.13],0.625780713256992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.02 [0.94-1.11],0.626098928155574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ALCAM,CD166 antigen,Inverse variance weighted,6,1.09 [0.78-1.52],0.626983509089674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.03 [0.93-1.14],0.62735495553387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.83 [0.4-1.74],0.628062908854385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.97 [0.88-1.08],0.629682074924244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.94 [0.74-1.2],0.629750139888394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.96 [0.81-1.13],0.631423146502148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG3,Secretogranin-3,Inverse variance weighted,32,1.02 [0.94-1.11],0.634887661120139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.03 [0.91-1.17],0.635467378135657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.08 [0.77-1.52],0.641562196208437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MB,Myoglobin,Wald ratio,1,1.32 [0.41-4.31],0.642992943882947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.93-1.12],0.643695508680007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.92 [0.66-1.29],0.644731520579358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.91-1.06],0.646645974053869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.94 [0.73-1.22],0.648059822962673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.04 [0.89-1.21],0.648413369805192,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.11 [0.7-1.77],0.649784283244443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD160,CD160 antigen,Inverse variance weighted,11,0.97 [0.84-1.11],0.650043350470144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.96-1.07],0.651249786251766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.93 [0.69-1.26],0.651985649713261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.9 [0.58-1.4],0.652535235499445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.05 [0.86-1.28],0.65393254562398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.02 [0.94-1.11],0.655295588848488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MELTF,Melanotransferrin,Inverse variance weighted,40,0.99 [0.92-1.05],0.658563594601979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALB2,Calretinin,Wald ratio,1,1.18 [0.57-2.42],0.660369245818873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN5,CCN family member 5,Inverse variance weighted,8,1.1 [0.73-1.66],0.6614160859408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.02 [0.94-1.1],0.666602407366178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.98 [0.89-1.08],0.670801934770272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [0.94-1.11],0.6729065426088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.03 [0.89-1.2],0.674558554686796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1.02 [0.95-1.09],0.678943473345455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.81 [0.29-2.24],0.679700116367675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.97 [0.84-1.12],0.681819100733567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.05 [0.83-1.34],0.688502410896437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NXPH3,Neurexophilin-3,Inverse variance weighted,11,0.97 [0.82-1.14],0.688670780742757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.94 [0.71-1.26],0.69113262685899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD276,CD276 antigen,Inverse variance weighted,20,1.02 [0.94-1.09],0.693374386367608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPC1,Glypican-1,Inverse variance weighted,17,1.02 [0.91-1.15],0.693981843375119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.23 [0.43-3.52],0.695665879983367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.22 [0.45-3.28],0.696144088134541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.11 [0.65-1.89],0.701049857268826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.96 [0.75-1.21],0.705117279035244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.88-1.21],0.706218042901701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.07 [0.75-1.54],0.707038864267955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.05 [0.82-1.35],0.707960111221367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK6,Kallikrein-6,Inverse variance weighted,4,1.04 [0.84-1.3],0.709518170339946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.94-1.09],0.71011882041101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.98 [0.88-1.09],0.714318794494435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,25,0.98 [0.87-1.1],0.714767697900541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VGF,Neurosecretory protein VGF,Wald ratio,1,1.26 [0.37-4.25],0.714837604349274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.08 [0.71-1.65],0.718054404485546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.08 [0.72-1.61],0.719219412564069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.95 [0.7-1.28],0.721082148209297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.92-1.06],0.721780182927755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.06 [0.78-1.44],0.724429651869818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.97 [0.81-1.16],0.724782770286554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.26 [0.35-4.6],0.72479660840668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,27,1.01 [0.94-1.1],0.727477323669795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.95 [0.71-1.27],0.73220372817572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.03 [0.88-1.21],0.732251791843401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.97 [0.82-1.15],0.732754839563521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.02 [0.91-1.14],0.735543752231956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.93 [0.6-1.43],0.736246341662224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD46,Membrane cofactor protein,Wald ratio,1,1.09 [0.66-1.8],0.737457974048956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.96 [0.74-1.24],0.739060794640929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRN,Agrin,Inverse variance weighted,17,0.98 [0.86-1.12],0.741853995652215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.98 [0.88-1.09],0.743108171075973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CX3CL1,Fractalkine,Inverse variance weighted,9,1.05 [0.78-1.43],0.74417774085578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAP,Prosaposin,Inverse variance weighted,5,0.97 [0.79-1.18],0.745758214930109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRELP,Prolargin,Inverse variance weighted,9,0.98 [0.86-1.12],0.746070867930852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.96 [0.77-1.21],0.748279887058658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMB,RGM domain family member B,Inverse variance weighted,9,0.97 [0.78-1.2],0.75022565450709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.98 [0.89-1.09],0.750312297588959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.98 [0.89-1.09],0.753952722763065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.95-1.07],0.76056389303871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSO,Cathepsin O,Inverse variance weighted,6,0.97 [0.79-1.19],0.764643848381919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.01 [0.96-1.06],0.765463262602888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,1.04 [0.82-1.31],0.76676784630721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.03 [0.84-1.26],0.767688942595967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.99 [0.91-1.07],0.768431342813442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.96 [0.72-1.28],0.769767871267617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.91-1.07],0.773162047733361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,1.02 [0.9-1.15],0.774356598191403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.94-1.09],0.776007791125268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.05 [0.73-1.53],0.779872705405993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KITLG,Kit ligand,Wald ratio,1,1.13 [0.47-2.72],0.783911554788553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.98 [0.85-1.13],0.787404365763812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGB6,Integrin beta-6,Inverse variance weighted,11,0.98 [0.87-1.11],0.789737161277813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.96 [0.74-1.26],0.790059106946206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.01 [0.93-1.1],0.795108954915558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN15,Lipocalin-15,Inverse variance weighted,20,1.01 [0.94-1.08],0.796045504965922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.95 [0.63-1.44],0.800551195238287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.96 [0.71-1.3],0.800848224011879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.01 [0.93-1.09],0.80449697591001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.07 [0.62-1.84],0.807599665086816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.96 [0.69-1.34],0.8092232665272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.88-1.1],0.810468958594569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.95 [0.65-1.4],0.813365919794798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.98 [0.83-1.16],0.814109407285133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.02 [0.89-1.15],0.816632542422922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.87-1.12],0.819627862232982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON2,Spondin-2,Inverse variance weighted,4,1.03 [0.78-1.38],0.822539562899898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.01 [0.89-1.15],0.822591340991659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.08 [0.55-2.12],0.822847370333713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.06 [0.64-1.76],0.824931355829619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSL,Cathepsin L1,Wald ratio,1,0.9 [0.34-2.36],0.826295074575477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GRN,Progranulin,Inverse variance weighted,7,1.02 [0.88-1.17],0.82708812655563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,0.99 [0.87-1.12],0.828989035188827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.98 [0.81-1.18],0.832055445043398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.88-1.18],0.832121532242784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.99 [0.88-1.11],0.833921067205909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.98 [0.79-1.22],0.834037764477534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.01 [0.89-1.16],0.834874788807226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.02 [0.87-1.19],0.834973126136721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BOC,Brother of CDO,Inverse variance weighted,6,1.02 [0.84-1.23],0.836666579577886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.02 [0.83-1.26],0.838133604494009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.01 [0.88-1.17],0.839602318474894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.01 [0.93-1.09],0.840610236700757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.07 [0.53-2.18],0.843343221791402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.01 [0.93-1.09],0.848346780799714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.96 [0.59-1.54],0.852330180667231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANG,Angiogenin,Inverse variance weighted,19,0.99 [0.89-1.1],0.855937110034695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.03 [0.76-1.39],0.857050748329095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,19,0.99 [0.87-1.13],0.858687158864115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.03 [0.74-1.44],0.863351880534228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.9-1.09],0.864022622847482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.98 [0.8-1.21],0.864830374022358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.99 [0.86-1.13],0.865670665261706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RETN,Resistin,Inverse variance weighted,9,1.01 [0.91-1.11],0.866467310494413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,0.99 [0.9-1.09],0.86711673854301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.95 [0.53-1.71],0.870877284189201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.87-1.12],0.872649724849689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.02 [0.8-1.3],0.879821114607961,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.99 [0.89-1.11],0.8810522456199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.98 [0.74-1.29],0.883083254649737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.99 [0.81-1.21],0.885018893459123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.99 [0.85-1.15],0.886897790173486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.92-1.08],0.889612859507302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.99 [0.85-1.15],0.893411943341263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.96 [0.54-1.7],0.893570550887099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.05 [0.52-2.13],0.897648986865376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.02 [0.73-1.42],0.897884859140254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.01 [0.92-1.1],0.899293178624184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.87-1.17],0.902659559055903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.99 [0.77-1.25],0.903259418952099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.03 [0.67-1.56],0.905773079408447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.02 [0.73-1.42],0.906991301698295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,1 [0.94-1.07],0.909213095251368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTBDN,Retbindin,Inverse variance weighted,3,1.01 [0.79-1.3],0.910303581883342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1 [0.93-1.07],0.915206708755649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ELN,Elastin,Inverse variance weighted,2,1.04 [0.47-2.32],0.919316111088855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.91-1.1],0.922529966637501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.02 [0.75-1.38],0.922542883948057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1 [0.94-1.07],0.927214953886905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,1.01 [0.89-1.14],0.92858899420079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.01 [0.76-1.35],0.93059760215148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP10,Stromelysin-2,Inverse variance weighted,22,1 [0.89-1.12],0.939686903516896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.92-1.09],0.940164953093097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THBD,Thrombomodulin,Inverse variance weighted,5,0.99 [0.8-1.23],0.940644213626466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.98 [0.58-1.66],0.941112196236816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.01 [0.71-1.45],0.950740620099549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REN,Renin,Inverse variance weighted,4,0.99 [0.79-1.25],0.95276079543369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1 [0.94-1.06],0.955013694926899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPP1,Osteopontin,Inverse variance weighted,8,0.99 [0.62-1.56],0.955156547766063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH1,Cadherin-1,Wald ratio,1,1.03 [0.39-2.67],0.959201952853775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,8,1 [0.85-1.17],0.959434353890359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH3,Cadherin-3,Inverse variance weighted,2,1.01 [0.6-1.7],0.960363853899297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.82-1.21],0.963267446593391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1 [0.82-1.24],0.965224287159409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK8,Kallikrein-8,Inverse variance weighted,12,1 [0.84-1.18],0.971690201762173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1 [0.94-1.07],0.972400809167956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.99 [0.43-2.25],0.97322567179091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANXA5,Annexin A5,Inverse variance weighted,2,0.99 [0.65-1.51],0.974014119775802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.91-1.1],0.975991359321438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1 [0.8-1.24],0.976596974456584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,1 [0.93-1.07],0.981013124537702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1 [0.74-1.36],0.981957483512757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1 [0.84-1.19],0.990433550161631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OGN,Mimecan,Inverse variance weighted,30,1 [0.9-1.12],0.991102622740646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VASN,Vasorin,Inverse variance weighted,14,1 [0.89-1.12],0.991156165982788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1 [0.81-1.24],0.991816851825872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1 [0.47-2.13],0.995427374974923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,29,1 [0.9-1.11],0.996514086291032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,2.34 [1.44-3.81],0.000648398015547878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,15,1.45 [1.15-1.84],0.0019666347144107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCA,Calcitonin,Inverse variance weighted,13,0.65 [0.5-0.86],0.00212948294299758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSC2,Desmocollin-2,Inverse variance weighted,16,0.82 [0.72-0.93],0.0027934970541633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.57 [1.17-2.11],0.00288349942074786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.99 [1.23-3.21],0.00481993211997255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,2.38 [1.3-4.35],0.0049525246898177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ALCAM,CD166 antigen,Inverse variance weighted,4,0.67 [0.5-0.89],0.00680244033942206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLC,Galectin-10,Inverse variance weighted,14,1.33 [1.08-1.65],0.00831062040413055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLK1,Protein delta homolog 1,Inverse variance weighted,10,1.49 [1.11-2.01],0.00840998044756579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,9,1.3 [1.07-1.57],0.00842672422063025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,2.13 [1.2-3.78],0.0100352484953613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK6,Kallikrein-6,Inverse variance weighted,2,2.14 [1.18-3.88],0.0123530281618513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.61 [1.1-2.37],0.0146612321544522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.2 [1.04-1.4],0.0150215978964044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.26 [0.08-0.78],0.0164049985462093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,XG,Glycoprotein Xg,Inverse variance weighted,2,0.41 [0.19-0.85],0.0169179589946232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.12 [1.02-1.22],0.0192153971956237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPT,Dermatopontin,Inverse variance weighted,4,0.53 [0.31-0.91],0.0218245969189948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,1.89 [1.09-3.31],0.0243776778325284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,2.06 [1.08-3.91],0.0279546348930985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WNT9A,Protein Wnt-9a,Wald ratio,1,4.03 [1.16-13.98],0.0280124158985594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.11 [1.01-1.21],0.0287271235510151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,3.11 [1.12-8.61],0.0289794907030703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.54 [0.31-0.94],0.0291804479888031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.41 [0.18-0.92],0.0312610915190024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST3,Cystatin-C,Inverse variance weighted,3,1.93 [1.06-3.52],0.0324060796191257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.81 [1.05-3.11],0.0328780695703365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.42 [1.03-1.97],0.0334606026076268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.82 [0.68-0.99],0.036271161096919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP6,Gastrotropin,Inverse variance weighted,4,0.49 [0.25-0.96],0.0364128597435478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LMNB2,Lamin-B2,Inverse variance weighted,8,0.68 [0.48-0.98],0.0384362547909658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.69 [1.05-6.87],0.0389683060352442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.53 [1.02-2.3],0.0411649057867466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGB,Secretogranin-1,Inverse variance weighted,7,1.31 [1.01-1.7],0.0438768039886736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.5 [1.01-2.22],0.0446464845926116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.15 [1-1.32],0.0460585675938985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.32 [1-1.73],0.0462750216430799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.95 [0.9-1],0.0480828183209752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.48 [1-2.19],0.0487634765934404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.82 [0.68-1],0.0491743464268483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.67 [0.44-1],0.0510835067715719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.78 [0.6-1],0.0529455356451541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,0.86 [0.74-1],0.0530335865884566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.74 [0.54-1.01],0.0571936497027739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.59 [0.98-2.56],0.0587379286277863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL11,Eotaxin,Inverse variance weighted,11,1.15 [0.99-1.34],0.0600074242029306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.29 [0.99-1.67],0.0602733838135929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.13 [0.99-1.29],0.0643289479423565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH3,Cadherin-3,Inverse variance weighted,10,0.74 [0.53-1.02],0.0652590213951705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.36 [0.98-1.88],0.0696224041695648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.8 [0.63-1.02],0.0700062162605879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAYN,Layilin,Inverse variance weighted,3,1.76 [0.95-3.25],0.0714767046454076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.27 [0.97-1.66],0.0767159169589115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.24 [0.97-1.58],0.0898009042585173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.12 [0.98-1.27],0.0923921939112394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.27 [0.96-1.69],0.0984236693557598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.21 [0.97-1.51],0.0989869106191844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.92 [0.83-1.02],0.0994837569505806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.69 [0.45-1.07],0.100411624480142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.06 [0.99-1.15],0.100810036345026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.81 [0.64-1.04],0.101060424983023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.63 [0.37-1.09],0.101703459841916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAP,Prosaposin,Inverse variance weighted,13,0.89 [0.77-1.03],0.10892524125603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.18 [0.96-1.44],0.109193562679332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.16 [0.97-1.38],0.109556344909441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM,Paralemmin-1,Inverse variance weighted,4,0.71 [0.46-1.08],0.110161052471046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,0.84 [0.67-1.04],0.112200622376613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPP1,Osteopontin,Inverse variance weighted,13,1.31 [0.94-1.83],0.112835249799187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.91 [0.8-1.02],0.114255802523309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.19 [0.96-1.48],0.114843262041283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.91 [0.82-1.02],0.116070382759982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.63 [0.88-3.01],0.117547255245434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.62 [0.34-1.13],0.118472087415435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.15 [0.97-1.36],0.11931202435507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.15 [0.96-1.38],0.120997447689014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NXPH3,Neurexophilin-3,Inverse variance weighted,19,0.92 [0.84-1.02],0.121592648722445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,0.44 [0.16-1.25],0.123314378483163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.73 [0.49-1.09],0.12603453150337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.38 [0.91-2.08],0.12662877419531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.38 [0.91-2.09],0.128431450484374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.87 [0.73-1.04],0.129092788909636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,1.41 [0.9-2.2],0.129479157085218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.46 [0.17-1.25],0.129774025849585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.81 [0.61-1.07],0.133872732267905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NFASC,Neurofascin,Inverse variance weighted,6,0.64 [0.36-1.15],0.134183086659614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DRAXIN,Draxin,Inverse variance weighted,25,1.13 [0.96-1.32],0.134584109446377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.42 [0.9-2.27],0.135214011870215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.54 [0.87-2.72],0.135619356952959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.25 [0.93-1.69],0.137699807671607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.45 [0.89-2.38],0.139231773300752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.2 [0.94-1.53],0.142462783392342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.27 [0.92-1.74],0.143085467952668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.53 [0.86-2.72],0.150102318932144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.09 [0.97-1.23],0.1526044212544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.14 [0.95-1.35],0.153063574903806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.27 [0.91-1.76],0.153065260690619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,23,1.07 [0.98-1.17],0.1555158426391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.22 [0.93-1.62],0.157018796846159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.39 [0.88-2.2],0.158192420202719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SDC1,Syndecan-1,Inverse variance weighted,12,0.85 [0.68-1.07],0.159795931310104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG2,Secretogranin-2,Inverse variance weighted,2,1.49 [0.85-2.6],0.161464572714437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.13 [0.95-1.34],0.161953795117241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.37 [0.88-2.13],0.163975865558164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,28,0.94 [0.87-1.03],0.168288618558643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.78 [0.55-1.11],0.170656875485701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.17 [0.93-1.45],0.176381069734496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.81 [0.6-1.1],0.180974783395142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.82 [0.76-4.35],0.18123916162353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON1,Spondin-1,Inverse variance weighted,4,1.46 [0.84-2.53],0.183131097172679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KITLG,Kit ligand,Inverse variance weighted,30,1.1 [0.96-1.27],0.183445342145829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.86 [0.69-1.08],0.184849954787609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,1.59 [0.8-3.17],0.185226992844891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.79 [0.56-1.12],0.185357942562221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.13 [0.94-1.35],0.189189328222269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.93 [0.82-1.04],0.190839102273033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.82 [0.62-1.1],0.192645204948359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.55 [0.22-1.36],0.194393505804539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.8 [0.56-1.12],0.194958068906267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.43 [0.83-2.48],0.197267454118898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.51 [0.18-1.42],0.197383450801264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.93 [0.82-1.04],0.198536580770017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MDK,Midkine,Inverse variance weighted,14,0.86 [0.68-1.08],0.19995098802907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.71 [0.42-1.2],0.200748288443186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.28 [0.88-1.87],0.201051916975817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.69 [0.4-1.22],0.203770303513548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.26 [0.88-1.81],0.20390201871192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.74 [0.47-1.18],0.206390953160434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.04 [0.98-1.11],0.206526420942573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.16 [0.92-1.47],0.209129211107564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.7 [0.4-1.23],0.211863652994169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.62 [0.3-1.31],0.214668291863314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL19,Interleukin-19,Inverse variance weighted,10,1.11 [0.94-1.32],0.215046325892585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.15 [0.92-1.44],0.217343719057966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTBDN,Retbindin,Inverse variance weighted,2,1.55 [0.77-3.13],0.217721494815073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP10,Stromelysin-2,Wald ratio,1,0.5 [0.16-1.53],0.224642278273465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRELP,Prolargin,Inverse variance weighted,5,0.7 [0.4-1.25],0.231029329500402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.14 [0.92-1.41],0.235430602270892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.92 [0.81-1.05],0.236018335437215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.82 [0.59-1.14],0.237224085530912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.17 [0.9-1.52],0.238977202891965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,14,0.94 [0.86-1.04],0.240140134226186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.25 [0.86-1.81],0.241100240816509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.22 [0.88-1.69],0.241694964428803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.09 [0.95-1.25],0.241723680025705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.48 [0.77-2.85],0.242307150906858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH1,Cadherin-1,Inverse variance weighted,16,0.9 [0.75-1.07],0.242472257227822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THBD,Thrombomodulin,Inverse variance weighted,11,1.11 [0.93-1.33],0.245346028886069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.52 [0.75-3.07],0.248055584074996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.7 [0.38-1.29],0.252406864330934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.67 [0.34-1.33],0.252675202490621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.24 [0.86-1.79],0.252775186199275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.96 [0.88-1.03],0.25505270560191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.27 [0.84-1.94],0.255876404244854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.52 [0.74-3.13],0.256381256747595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MB,Myoglobin,Inverse variance weighted,9,0.76 [0.48-1.22],0.256861560393134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.96 [0.88-1.03],0.259760390425344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.62 [0.27-1.42],0.26022394215672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.24 [0.85-1.81],0.262546780212103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD302,CD302 antigen,Inverse variance weighted,11,0.89 [0.72-1.1],0.267848016569235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.12 [0.91-1.38],0.271178019351349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.03 [0.97-1.1],0.273399902842878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI3,Elafin,Inverse variance weighted,18,1.1 [0.93-1.3],0.278956428953613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.6 [0.68-3.79],0.280269199759074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.89 [0.73-1.1],0.284878374067229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.73 [0.41-1.3],0.285054609466242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.18 [0.87-1.61],0.288063956627831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.18 [0.87-1.62],0.289034160019867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD70,CD70 antigen,Inverse variance weighted,11,0.91 [0.77-1.08],0.289228497709121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.42 [0.74-2.73],0.292516588743676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.15 [0.89-1.48],0.294606641239042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSB,Cathepsin B,Inverse variance weighted,28,1.07 [0.94-1.21],0.29556548255821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD27,CD27 antigen,Inverse variance weighted,9,0.84 [0.6-1.17],0.2975146672572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.76 [0.45-1.28],0.300088489435931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.97 [0.92-1.03],0.301018589039717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VWC2,Brorin,Inverse variance weighted,12,1.21 [0.84-1.75],0.302329124434087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.84 [0.6-1.17],0.302857887872737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.35 [0.76-2.41],0.30697305731041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.91 [0.76-1.09],0.308880289366715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.94 [0.85-1.06],0.311504574483341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.19 [0.85-1.67],0.312630799376769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.95 [0.87-1.05],0.31347499712425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.77 [0.58-5.41],0.316636283748131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG3,Desmoglein-3,Inverse variance weighted,27,0.94 [0.84-1.06],0.319037585862142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.21 [0.83-1.76],0.329648551407273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.81 [0.52-1.25],0.330567321095023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.67 [0.3-1.5],0.331751629228855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP7,Matrilysin,Wald ratio,1,0.82 [0.55-1.23],0.336557600080234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN5,CCN family member 5,Inverse variance weighted,12,0.91 [0.76-1.1],0.340206732108468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSO,Cathepsin O,Inverse variance weighted,19,1.09 [0.91-1.31],0.341478630455692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.14 [0.87-1.51],0.343472212024586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.69 [0.57-4.99],0.344300275373178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.31 [0.75-2.31],0.345865379212818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.88 [0.67-1.15],0.348865568686413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.09 [0.91-1.29],0.350308308962559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.71 [0.34-1.46],0.350332330007739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.16 [0.85-1.6],0.350967269082509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.12 [0.88-1.44],0.352541052237323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.9 [0.73-1.12],0.356758436119997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.87-1.05],0.357238464925415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.06 [0.93-1.22],0.359573510820901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNB2,Ephrin-B2,Wald ratio,1,1.14 [0.86-1.53],0.361327735894357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.04 [0.96-1.12],0.362400907047648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.34 [0.71-2.52],0.365262542061842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.51 [0.62-3.66],0.36545518751568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.87 [0.65-1.17],0.36607244990077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.95 [0.84-1.07],0.366319035900469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.55 [0.15-2.03],0.367375298670998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.31 [0.72-2.39],0.370675901948298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.43 [0.65-3.17],0.377480300351177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.94 [0.82-1.08],0.378746717923178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.1 [0.89-1.37],0.379489146972757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD164,Sialomucin core protein 24,Inverse variance weighted,8,0.89 [0.69-1.15],0.381412037517679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.09 [0.9-1.31],0.384336121037516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.85 [0.59-1.23],0.386698598388978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK10,Kallikrein-10,Wald ratio,1,0.6 [0.19-1.93],0.39181460966607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK14,Kallikrein-14,Inverse variance weighted,15,1.11 [0.87-1.42],0.393430826887862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.05 [0.94-1.18],0.397436120485511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.2 [0.79-1.83],0.399288799259632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.26 [0.73-2.15],0.408047542556858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.87 [0.63-1.21],0.415959484198339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,0.95 [0.84-1.07],0.422863130916023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.16 [0.81-1.66],0.428785170955838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.39 [0.61-3.15],0.429832631792065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.84 [0.56-1.28],0.429895541748787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.71 [0.3-1.66],0.432104237595611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.11 [0.85-1.44],0.433049176355439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.09 [0.88-1.34],0.433800429923123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.93 [0.78-1.12],0.434587837690208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.93 [0.76-1.13],0.437270518626085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.69 [0.27-1.75],0.438478505719319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.81 [0.48-1.38],0.442016519759921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANG,Angiogenin,Inverse variance weighted,9,0.86 [0.59-1.26],0.443008307870293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.27 [0.69-2.32],0.446252677310353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.92 [0.75-1.14],0.451241939085525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.3 [0.65-2.61],0.452284119547152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.14 [0.8-1.63],0.453364182949175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,5,0.84 [0.53-1.33],0.455803500888931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.78 [0.41-1.5],0.455919408974901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,0.96 [0.85-1.07],0.457538368948648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.03 [0.95-1.13],0.462039377887208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ELN,Elastin,Inverse variance weighted,10,0.9 [0.67-1.2],0.466498366549003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.03 [0.96-1.1],0.468356997726528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG3,Secretogranin-3,Inverse variance weighted,16,0.92 [0.75-1.14],0.46977971757905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HEPH,Hephaestin,Inverse variance weighted,6,1.07 [0.88-1.31],0.472929386681316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CX3CL1,Fractalkine,Inverse variance weighted,12,1.16 [0.78-1.72],0.477095022119792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NRP1,Neuropilin-1,Inverse variance weighted,14,0.91 [0.69-1.19],0.479788602731074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.05 [0.92-1.2],0.481066414202322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.84 [0.52-1.36],0.481610250989099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.95 [0.84-1.09],0.482063064754551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.75 [0.33-1.68],0.482231703760965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.23 [0.69-2.2],0.484748621301083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.89 [0.64-1.24],0.484768239994084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRN,Agrin,Inverse variance weighted,14,1.12 [0.81-1.55],0.485522131254028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON2,Spondin-2,Inverse variance weighted,3,0.72 [0.29-1.82],0.488060784005886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.11 [0.83-1.48],0.490507953115233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.94 [0.78-1.13],0.492921933142631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,17,1.05 [0.91-1.21],0.497533365087107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.21 [0.69-2.13],0.497881532534079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.91 [0.69-1.2],0.498579230373752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.14 [0.78-1.65],0.498822460757558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.86 [0.57-1.32],0.501486184289574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.09 [0.85-1.39],0.502166976355206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.44 [0.5-4.16],0.505398795982031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.91 [0.68-1.21],0.510116647065763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1.05 [0.91-1.2],0.510217638315284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,1.03 [0.94-1.13],0.513807871041758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.9 [0.66-1.23],0.515170024657962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.8 [0.4-1.58],0.51658490921594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.9 [0.65-1.25],0.518218140343908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP3,Stromelysin-1,Inverse variance weighted,4,0.82 [0.46-1.48],0.520652672643545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.09 [0.84-1.42],0.522167180017028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.17 [0.72-1.92],0.525154325564889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.07 [0.86-1.34],0.526216659660829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPC1,Glypican-1,Inverse variance weighted,28,0.95 [0.81-1.11],0.526278520994155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.24 [0.64-2.41],0.526330939759663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.06 [0.88-1.28],0.527072508556253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.94 [0.76-1.15],0.531970644407478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.93 [0.75-1.16],0.532327090474828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.94 [0.78-1.14],0.533759041514436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.89-1.07],0.539226824042581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.08 [0.84-1.38],0.54389519809035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.81 [0.42-1.59],0.548092982301835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.04 [0.91-1.2],0.549062370633043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.02 [0.95-1.11],0.549232287719047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.07 [0.87-1.31],0.549496169140203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,4,0.83 [0.45-1.54],0.554963483040005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,5,1.13 [0.75-1.71],0.555340607690258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AREG,Amphiregulin,Inverse variance weighted,5,1.14 [0.74-1.73],0.555640192632197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.83 [0.44-1.55],0.556644168987073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.15 [0.71-1.86],0.55900786809216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRP,Agouti-related protein,Inverse variance weighted,16,0.94 [0.77-1.15],0.56573436511873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.07 [0.85-1.34],0.566336127153321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.21 [0.62-2.36],0.566809898199822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,8,0.93 [0.71-1.21],0.568049161752631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.88 [0.57-1.36],0.568557228805027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.91 [0.64-1.27],0.569004244203598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.88 [0.57-1.36],0.57136069450302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.11 [0.77-1.6],0.571802794854446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GCG,Pro-glucagon,Inverse variance weighted,2,1.48 [0.38-5.85],0.575062255207101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VASN,Vasorin,Inverse variance weighted,5,1.26 [0.56-2.81],0.575860427107304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD48,CD48 antigen,Inverse variance weighted,14,0.93 [0.7-1.22],0.577692599404841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.97 [0.86-1.09],0.578781280543938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.1 [0.79-1.52],0.578819894223559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.13 [0.74-1.73],0.581125523967556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.05 [0.89-1.24],0.582597830450721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.94 [0.76-1.16],0.584659771256257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.13 [0.73-1.74],0.58620895187359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.12 [0.74-1.71],0.58639130286142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.96 [0.81-1.13],0.59067335759749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.06 [0.86-1.3],0.59126633404911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EGFLAM,Pikachurin,Wald ratio,1,0.68 [0.17-2.79],0.594064268198049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.07 [0.83-1.38],0.595214327259707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.14 [0.71-1.83],0.597009288935162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.05 [0.88-1.25],0.607095119798176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CAPG,Macrophage-capping protein,Wald ratio,1,1.24 [0.54-2.84],0.610253356429232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.05 [0.87-1.26],0.612356988201955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.02 [0.93-1.13],0.613737218142693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.95 [0.78-1.15],0.614557374846198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.95 [0.8-1.15],0.617561381327892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.11 [0.73-1.7],0.618024493396002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RETN,Resistin,Inverse variance weighted,19,0.93 [0.72-1.22],0.620520290016877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.93 [0.72-1.22],0.621113695592668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN4,Nectin-4,Inverse variance weighted,4,0.85 [0.44-1.63],0.621707214150836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,POF1B,Protein POF1B,Inverse variance weighted,4,0.87 [0.5-1.52],0.624030123748508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.83 [0.4-1.74],0.628062908854385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.06 [0.84-1.33],0.634011487452727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.85 [0.43-1.66],0.634328380470345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.94-1.11],0.636595244795987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MELTF,Melanotransferrin,Inverse variance weighted,10,1.08 [0.79-1.48],0.63961458840765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD160,CD160 antigen,Inverse variance weighted,24,0.96 [0.79-1.15],0.642205815366595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.01 [0.97-1.05],0.644461892743361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.05 [0.85-1.3],0.644484222667054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.87-1.09],0.647975350412939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.05 [0.85-1.29],0.651766093618817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.97 [0.86-1.1],0.657814457435958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.92 [0.64-1.33],0.667003171669285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH6,Cadherin-6,Inverse variance weighted,5,1.11 [0.69-1.76],0.669084886165103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.98 [0.87-1.09],0.669561487755745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.86 [0.44-1.7],0.672252031919251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.88 [0.48-1.61],0.675096643300582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.92 [0.61-1.38],0.677676282697622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.08 [0.76-1.53],0.68288936640085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.02 [0.93-1.11],0.689738507729198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.93-1.05],0.690569352602849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.07 [0.77-1.48],0.692763393694032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PKD1,Polycystin-1,Inverse variance weighted,12,0.95 [0.71-1.25],0.695741497609323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.94 [0.69-1.29],0.698556402731361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.04 [0.86-1.25],0.699366473198581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.91 [0.57-1.45],0.699796655286959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.94 [0.67-1.31],0.705289655796106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DCN,Decorin,Inverse variance weighted,2,0.86 [0.4-1.87],0.707025978549363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD99,CD99 antigen,Inverse variance weighted,4,0.93 [0.65-1.34],0.708869519935098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN15,Lipocalin-15,Inverse variance weighted,22,0.98 [0.91-1.07],0.709079140357532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,UMOD,Uromodulin,Inverse variance weighted,34,1.03 [0.87-1.23],0.711416089267194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMB,RGM domain family member B,Inverse variance weighted,5,0.86 [0.38-1.92],0.711766317612666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,1.13 [0.58-2.21],0.715143828783783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.04 [0.84-1.28],0.716220357118652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.1 [0.67-1.8],0.716510899957501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.89 [0.47-1.68],0.721283443891157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.22 [0.41-3.67],0.721420511135834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.72-1.26],0.721684230231981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REN,Renin,Inverse variance weighted,8,1.06 [0.77-1.46],0.722752741734159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.07 [0.74-1.54],0.726479422620621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.91 [0.52-1.58],0.729333878674019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.03 [0.88-1.2],0.730281797659668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.08 [0.68-1.72],0.732194423386503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST6,Cystatin-M,Inverse variance weighted,26,1.03 [0.86-1.25],0.734550593951159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,0.84 [0.3-2.33],0.736912064734562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,1.04 [0.81-1.35],0.742396745807894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.97 [0.79-1.18],0.745290506867642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.92 [0.56-1.52],0.746498364086903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.04 [0.84-1.28],0.748698654941829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.15 [0.48-2.74],0.748875621939871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.94 [0.65-1.37],0.752142695931878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.98 [0.88-1.09],0.754987974310648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.85 [0.32-2.29],0.755085258647933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.04 [0.81-1.34],0.755863545702925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.19 [0.4-3.53],0.759005339983999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.98 [0.84-1.14],0.759873229447322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MUC13,Mucin-13,Inverse variance weighted,3,0.91 [0.5-1.67],0.760189321645067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.06 [0.71-1.58],0.769237444156663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.95 [0.68-1.34],0.771589455832814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.94-1.09],0.77957108778324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.11 [0.54-2.26],0.779645966623909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.06 [0.71-1.57],0.780417478665902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.98 [0.87-1.11],0.780575213080435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.15 [0.43-3.03],0.780781428124091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.96-1.06],0.788077191113097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,XCL1,Lymphotactin,Inverse variance weighted,15,0.96 [0.69-1.33],0.792106627656676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OCLN,Occludin,Inverse variance weighted,2,1.14 [0.42-3.12],0.793590418724849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PENK,Proenkephalin-A,Inverse variance weighted,15,1.03 [0.83-1.27],0.793662630734057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.02 [0.87-1.19],0.79372095727308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,F3,Tissue factor,Inverse variance weighted,13,0.96 [0.74-1.26],0.796040478921286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.06 [0.67-1.68],0.799140919097415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,0.95 [0.66-1.37],0.800148081196183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.02 [0.87-1.19],0.809248247390652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.98 [0.82-1.17],0.811959825099615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.02 [0.85-1.23],0.812032080063548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.1 [0.51-2.38],0.812571214740595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.98 [0.8-1.19],0.813777314358187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.93-1.1],0.814339229098435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS27,Serine protease 27,Inverse variance weighted,47,0.99 [0.91-1.08],0.816912209583173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.69-1.34],0.817330557688593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.99 [0.92-1.07],0.817654392497583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PPL,Periplakin,Inverse variance weighted,2,0.94 [0.52-1.68],0.824776506736303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,29,1.01 [0.9-1.14],0.825356436963747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.08 [0.53-2.19],0.827779265219152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,5,0.95 [0.57-1.56],0.828290034022383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.97 [0.72-1.3],0.829636431001416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FBLN2,Fibulin-2,Inverse variance weighted,6,0.96 [0.64-1.43],0.833881309153429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.06 [0.63-1.78],0.835974624819924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.16 [0.29-4.62],0.837634205720356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CFD,Complement factor D,Wald ratio,1,1.1 [0.43-2.81],0.839060788420527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.03 [0.75-1.42],0.839616549423968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.96 [0.68-1.37],0.839837300862948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.13 [0.35-3.66],0.841319854426881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.96 [0.63-1.46],0.848226563297537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.02 [0.82-1.27],0.850850529470653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.92-1.11],0.853992381379672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH17,Cadherin-17,Inverse variance weighted,31,0.99 [0.9-1.09],0.862652202394696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,0.98 [0.8-1.2],0.862949850776316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.98 [0.81-1.19],0.864421939166168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD276,CD276 antigen,Inverse variance weighted,24,0.99 [0.85-1.14],0.864934429979392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.99 [0.81-1.2],0.879598004125151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.03 [0.74-1.42],0.880036199550315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.97 [0.61-1.52],0.884140923462024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALB1,Calbindin,Inverse variance weighted,9,1.02 [0.79-1.32],0.884792967278729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.1 [0.3-3.95],0.887301028075403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.97 [0.59-1.57],0.888583557195395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK8,Kallikrein-8,Inverse variance weighted,5,0.97 [0.65-1.45],0.889387359331714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.04 [0.58-1.87],0.890372086900342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.02 [0.75-1.39],0.894594671525005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.98 [0.76-1.27],0.896180346747587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.01 [0.85-1.2],0.902684663317834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.98 [0.75-1.29],0.904025630798831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.83-1.18],0.904410702382722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.97 [0.58-1.63],0.904636055921431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.97 [0.62-1.53],0.909900782811434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.01 [0.83-1.22],0.911726596135082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,3,1.05 [0.43-2.59],0.912742420916491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.98 [0.68-1.41],0.919500774535865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.99 [0.87-1.13],0.920337124613525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,40,1 [0.91-1.09],0.924492900793862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.98 [0.68-1.43],0.926225435845427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GUCA2A,Guanylin,Inverse variance weighted,7,0.98 [0.69-1.4],0.928689107455192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.99 [0.78-1.26],0.934241972135826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.01 [0.79-1.29],0.936023946993648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.02 [0.65-1.59],0.936912822821697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.99 [0.7-1.4],0.940816685700623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.01 [0.73-1.4],0.942011370549741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.01 [0.74-1.38],0.942494130182971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS8,Prostasin,Inverse variance weighted,14,1.01 [0.82-1.24],0.944415347134287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1 [0.87-1.14],0.945812362725262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,3,1.02 [0.55-1.9],0.946757598488504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,0.99 [0.66-1.47],0.947058099175234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.02 [0.5-2.08],0.949143977874434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.02 [0.55-1.91],0.949978893950408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSL,Cathepsin L1,Inverse variance weighted,29,1 [0.87-1.16],0.951886837308884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,0.99 [0.8-1.24],0.951980568732644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.56-1.85],0.956833863282587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.01 [0.69-1.48],0.958952953857329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,5,0.99 [0.64-1.53],0.95925807845094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1 [0.88-1.13],0.959867968303305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OGN,Mimecan,Inverse variance weighted,37,1 [0.92-1.1],0.961214005879583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,16,1 [0.87-1.15],0.963145341690769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.99 [0.63-1.55],0.963268326125112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1 [0.86-1.16],0.963357061248174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BSG,Basigin,Inverse variance weighted,6,0.99 [0.61-1.61],0.964747083903009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD83,CD83 antigen,Inverse variance weighted,14,1.01 [0.75-1.35],0.965707330704262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.01 [0.79-1.28],0.966789198737559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,1 [0.84-1.18],0.968040664314609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1 [0.79-1.25],0.974598439747697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.01 [0.63-1.62],0.977255113878462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1 [0.74-1.35],0.978812891018703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.99 [0.43-2.26],0.980896546402723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1 [0.82-1.21],0.98507250137966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG2,Desmoglein-2,Inverse variance weighted,22,1 [0.87-1.15],0.985081111809427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1 [0.86-1.16],0.985957054166877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CKB,Creatine kinase B-type,Inverse variance weighted,11,1 [0.68-1.48],0.986048531633208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BOC,Brother of CDO,Inverse variance weighted,8,1 [0.75-1.33],0.986442119758953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1 [0.71-1.43],0.987558957159993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1 [0.91-1.1],0.988039941002917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1 [0.48-2.11],0.989598370141694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.91-1.1],0.991298493232502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1 [0.78-1.28],0.991542558203566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1 [0.81-1.24],0.991816851825872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1 [0.78-1.29],0.998980582073533,trans
